Louis Monti

Louis Monti

Corporate Officer/Principal at VISTAGEN THERAPEUTICS, INC.

Health Technology
Consumer Services
Commercial Services

Profile

Louis Monti is a member of the New York Academy of Sciences, the American Society of Clinical Psychopharmacology, and the International Brain Research Organization.
He is currently the Vice President of Translational Medicine at VistaGen Therapeutics, Inc. Dr. Monti was previously the President and CEO of Pherin Pharmaceuticals, Inc. from 2018 to 2020.
He holds a doctorate degree from the University of Utah and Universidad De La Republica Uruguay.

Louis Monti active positions

CompaniesPositionStart
VISTAGEN THERAPEUTICS, INC. Corporate Officer/Principal 01/12/2020
Corporate Officer/Principal -
American Society of Clinical Psychopharmacology Corporate Officer/Principal -
International Brain Research Organization Corporate Officer/Principal -
All active positions of Louis Monti

Former positions of Louis Monti

CompaniesPositionEnd
Chief Executive Officer 01/11/2020
See the detail of Louis Monti's experience

Training of Louis Monti

University of Utah Doctorate Degree
Universidad De La Republica Uruguay Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Louis Monti's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
VISTAGEN THERAPEUTICS, INC.

Health Technology

Private companies4

Health Technology

Commercial Services

American Society of Clinical Psychopharmacology

International Brain Research Organization

See company connections